[心力衰竭患者的节律管理]
Richard Kobza1, Benjamin Berte2
1Cardiopuls Medical Center Luzern, Luzern, Switzerland, richard.kobza@cardiopuls.ch.
Therapeutische Umschau. Revue therapeutique
|May 23, 2024
概括
在心力衰竭中控制心律失常需要一个全面的策略. 早期节律控制,包括导管切除,改善了心力衰竭患者心律不整的结果.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 心脏衰竭管理的管理
背景情况:
- 心律不整常见于心力衰竭,增加死亡风险.
- 目前心力衰竭中突然心脏死亡的风险分层具有挑战性.
- 抗心律失常药物提供症状缓解,但没有预后益处.
研究的目的:
- 审查目前在心力衰竭中管理心律失常的策略.
- 突出早期节律控制的作用,包括导管切除.
- 强调心力衰竭中的心律失常管理的多维方法.
主要方法:
- 综述最近的临床研究和关于心力衰竭心律失常管理的数据.
- 分析不同治疗策略的预后影响.
- 对基于设备和干预疗法的证据综合.
主要成果:
- 最近的数据支持了对静脉动心脏的导管切除的早期考虑.
- 早期节律控制策略,特别是导管切除,在心脏衰竭与心房动中显示出积极的预后影响.
- 一种系统的,多维的方法,整合医疗,设备和干预疗法至关重要.
结论:
- 在心力衰竭中整体管理心律失常,需要采用综合方法.
- 早期节律控制,特别是导管切除,提供了显著的预后优势.
- 需要进一步的研究和早期节律控制策略的临床实施.
更多相关视频
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
762
相关概念视频
Pulse rhythm
785
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
785
Disturbances in Heart Rhythm
936
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
936
Heart Failure Drugs: Inotropic Agents
570
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
570
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Decreased pulse rate
537
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
537
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
